Recent evidence has shown that, in spite of their structural similarity, CCN proteins have a diverse range of activities. In particular, results revealed using geneticallydeficient mice and cells derived thereof have revealed essential non-redundant functions for CCN family members. Targeted disruption of CCN2/CTGF identified a role in coordinating chondrogenesis and angiogenesis (Ivkovic et al. 2003) while knock out mice lacking CCN1/CYR61 show that it is required for placental development and vascular integrity (Mo et al. 2002) . Experiments using CCN2-deficient cells have shown that CCN2 is required for optimal adhesion, contraction, migration and gene transcription both basally and in response to fibronectin, transforming growth factor-beta 1 and micromass culture (Chen et al. 2004; Shi-wen et al. 2006; Kennedy et al. 2007; Nishida et al. 2007; Pala et al. 2008) . CCN3/nov (nephroblastoma overexpressed) was initially identified in a chick nephroblastoma caused by the mouse adenovirus type 1 (MAV-1) retrovirus (Joliot et al. 1992) . CCN3 is overexpressed in all MAV-induced avian nephroblastomas studied and deregulated in a variety of other tumor types, including Wilms' tumors (Chevalier et al. 1998 ) and musculoskeletal tumors (Manara et al. 2002) . Although these results suggest that CCN3 may contribute to tumorigenesis, whether CCN3 plays an essential role in vivo is unknown. To investigate the in vivo function of CCN3, Heath and colleagues (2008) generated mice carrying a targeted mutation of CCN3. These mice produce no full length NOV protein, but express at a barely detectable level a mutant NOV protein that lacks the van Willebrand domain. Mutating CCN3 resulted in abnormal skeletal and cardiac development, including joint abnormalities, cardiomyopathy, and premature tissue degeneration culminating in muscle atrophy and cataracts in adult mice. In development at E16.5, CCN3 expression was found in the mesenchyme surrounding cartilage condensations, and in the tendons and myotendinous junctions. Chondrocytes were enlarged and the region in which chondrocytes were present was enlarged. Ossification was severely impaired in mutant embryos. These results differed significantly from those seen in CCN2 knockout mice which die shortly after birth with severely malformed rib cages (Ivkovic et al. 2003) . In these latter animals, delayed ossification was also observed, but these mice had enlarged pre-hypertrophic/hypertrophic zones and thinner bone collars. In contrast, in CCN3 mutant mice, the size of the prehypertrophic/hypertrophic zone was reduced, and the bone collars were increased in thickness.
The basis of the phenotype of the CCN3-deficient mice was not explored mechanistically. It is unclear whether the phenotypes observed are due to the loss of full length CCN3, or to possible novel functions of the very low level of mutant CCN3 expression. Moreover, expression of key players in chondrogenesis and ossification (e.g., the sox family of transcription factors) were not examined. Moreover, it has been recently shown that CCN2, but not CCN3, is induced by Wnt3a, which plays a key role in signaling in chondrogenesis, osteoblastogenesis, and osteoclastogenesis (Si et al. 2006; Chen et al. 2008 ). An intriguing possibility exists that the differential results between the CCN2 and CCN3 animals may arise due to differential responses in expression to Wnt3a.
Nonetheless, the results presented by Heath and colleagues (2008) are intriguing at they point to clear functional differences in vivo among the different CCN family members. These differences which may reflect divergences not only regarding the proteins with which they interact with, but also regarding the expression patterns in response to various stimuli in vivo.
